Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion type Assertion NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_head.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion evidence source_evidence_literature NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion SIO_000772 23770046 NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion wasDerivedFrom befree-20150227 NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.
- NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion wasGeneratedBy ECO_0000203 NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.